PNT2258 for Treatment of Patients With r/r DLBCL (Wolverine)

Clinical trial NCT02226965 · COMPLETED

Trial details

NCT number: NCT02226965
Sponsor: Sierra Oncology LLC - a GSK company
Status: COMPLETED
Phase: Phase 2
Study type: INTERVENTIONAL

Lymphoma, Diffuse Large B-Cell

Start date: 2014-12-01
Primary completion: 2016-07-11
Enrollment: 45

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.